Adenocarcinoma: all 1,996 studies
Page 16 of 20. Open to participants first (369), then studies with results posted, then the rest; newest registration first within each.
- Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic AcidCompletedNCT02361515Not applicable
- Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract AdenocarcinomaCompletedNCT02346032Phase 2
- Phase 1b Study of CCX872-B in Patients With Pancreatic AdenocarcinomaCompletedNCT02345408Phase 1
- C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerWithdrawnNCT02344810Phase 1/2
- Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate CancerCompletedNCT02342626Not applicable
- HS-PCI in Locally Advanced Adenocarcinoma of the LungWithdrawnNCT02341170Not applicable
- Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate AdenocarcinomaCompletedNCT02339948Not applicable
- EUS-Guided Cryothermal Ablation in Patients With Stage III Pancreatic Adenocarcinoma (HybridTherm Study)CompletedNCT02336672Not applicable
- The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting HysterectomyStatus unknownNCT02335203Phase 2
- CTC Pancreatic AdenocarcinomaCompletedNCT02335151Phase 4
- Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT02333188Phase 1
- Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic AdenocarcinomaStatus unknownNCT02329717Phase 2
- Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02316834Early Phase 1
- Length of the Proximal Resection Margin for Siewert-II/Siewert-III TumorsStatus unknownNCT02313688Not applicable
- Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the PancreasWithdrawnNCT02310971Phase 2
- Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in FranceApproved for marketingNCT02307812
- Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRIActive, not recruitingNCT02306538
- Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4CompletedNCT02305368
- A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric AdenocarcinomaCompletedNCT02301481Phase 2
- Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal JunctionCompletedNCT02287129Phase 2
- Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid TumorsCompletedNCT02285101Phase 1
- High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain MetastasesStatus unknownNCT02284490Phase 2
- Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene MutationStatus unknownNCT02283424Phase 4
- Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal EsophagusTerminatedNCT02283359Phase 1
- Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal CancerCompletedNCT02270606Phase 1
- HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.Status unknownNCT02258087Phase 2/3
- A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients with Localized Prostate CancerCompletedNCT02254746Not applicable
- Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT02244489Phase 1
- Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.CompletedNCT02241499Phase 2
- Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric CancerStatus unknownNCT02240524Phase 3
- Telomere Biology in Early Adenocarcinoma of the LungStatus unknownNCT02239432
- Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal CancerWithdrawnNCT02235324Phase 2
- Pilot Study of DRibble Vaccine for Prostate Cancer PatientsCompletedNCT02234921Phase 1
- CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT02232152Phase 1
- A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic CancerCompletedNCT02231723Phase 1
- Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic AdenocarcinomaTerminatedNCT02207985Phase 1/2
- Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the PancreasWithdrawnNCT02205788
- Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the BreastCompletedNCT02204046Phase 1
- Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic CarcinomaCompletedNCT02195180Phase 2
- Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric AdenocarcinomaStatus unknownNCT02193594Phase 2/3
- EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung CancerCompletedNCT02183870Phase 2
- Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.CompletedNCT02181465Phase 2
- To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal CancersCompletedNCT02179970Phase 1
- Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric AdenocarcinomaStatus unknownNCT02177552Phase 2
- Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic CancerCompletedNCT02174887Phase 1
- CART-meso in Mesothelin Expressing CancersCompletedNCT02159716Phase 1
- Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic CancerCompletedNCT02153450Early Phase 1
- A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung AdenocarcinomaStatus unknownNCT02146118Phase 2
- A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric CancerStatus unknownNCT02144727Phase 3
- LDE225 + Everolimus in Advanced Gastroesophageal AdenocarcinomaCompletedNCT02138929Phase 1
- Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96Status unknownNCT02133079Phase 1/2
- Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing ChemoradiationCompletedNCT02132858
- Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2Status unknownNCT02132143Not applicable
- Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real DoseCompletedNCT02130011Not applicable
- Ovarian Clear Cell Adenocarcinoma ReviewCompletedNCT02129036
- Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric CancerCompletedNCT02128243Phase 2
- Whole-Exome Sequencing (WES) of Cancer PatientsCompletedNCT02127359
- Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung AdenocarcinomaStatus unknownNCT02125240Phase 3
- Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)TerminatedNCT02124369Phase 2
- Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-upTerminatedNCT02121925
- Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)TerminatedNCT02121899
- Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung AdenocarcinomasCompletedNCT02120807Phase 1
- Z-360 Plus GEM in Subjects With Metastatic Pancreatic AdenocarcinomaCompletedNCT02117258Phase 2
- Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the LiverTerminatedNCT02110953Phase 1
- Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung AdenocarcinomaStatus unknownNCT02103257Phase 4
- A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung AdenocarcinomaCompletedNCT02093000
- Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)CompletedNCT02081131Not applicable
- Comparison of Two Needles (19G Flex Versus 22G Standard) for Pancreatic Solid Tumors DiagnosisCompletedNCT02078232Not applicable
- Gastric Microperfusion in Patients Undergoing Gastroesophageal ResectionsCompletedNCT02077673
- Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient ManagementCompletedNCT02075905
- International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric CancerApproved for marketingNCT02065765
- Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the ProstateCompletedNCT02064036Phase 1
- A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic CancerCompletedNCT02048384Phase 1
- Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal CancerWithdrawnNCT02046538Phase 2
- A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic CancerCompletedNCT02045589Phase 1
- Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR MutationCompletedNCT02044328Phase 2
- FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal AdenocarcinomaActive, not recruitingNCT02037048Phase 2
- Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate CancerStatus unknownNCT02031328Phase 1/2
- Evaluation of PET/MRI in Patients With Pancreatic AdenocarcinomaCompletedNCT02028377Not applicable
- Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate BiopsyCompletedNCT02025361Phase 4
- Treatment Decision Analysis Model for Prostate Cancer: A Randomized TrialTerminatedNCT02024685Not applicable
- Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02023021Phase 2
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal AdenocarcinomaStatus unknownNCT02018367Phase 2
- Immunoscore in Rectal CancerCompletedNCT02017509
- Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid TumorsTerminatedNCT02016534Phase 2
- Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With MicroinvasionStatus unknownNCT02011997Phase 3
- MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerStatus unknownNCT02007148Phase 2
- Low Rectal Cancer Study (MERCURY II)Status unknownNCT02005965
- Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02005419Phase 2
- Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the ProstateTerminatedNCT01996696Phase 2
- Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) TrialStatus unknownNCT01995942
- Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After ProstatectomyActive, not recruitingNCT01994239Phase 2
- ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)TerminatedNCT01989858Phase 3
- PAncreatic Adenocarcinoma in HospitalCompletedNCT01989624
- Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)Status unknownNCT01971281Phase 1/2
- First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.CompletedNCT01964287Phase 1/2
- A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or LymphomaCompletedNCT01962532Phase 1
- Early Oral Feeding After Total Gastrectomy for CancerStatus unknownNCT01962519Not applicable
- Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric JunctionCompletedNCT01962246Phase 2/3